LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

NVO

111.95

+0.05%↑

JNJ

159.98

+0.01%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

NVO

111.95

+0.05%↑

JNJ

159.98

+0.01%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

NVO

111.95

+0.05%↑

JNJ

159.98

+0.01%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

NVO

111.95

+0.05%↑

JNJ

159.98

+0.01%↑

ABBV

203.23

-0.43%↓

LLY

817.59

-1.55%↓

UNH

566.44

+0.03%↑

NVO

111.95

+0.05%↑

JNJ

159.98

+0.01%↑

ABBV

203.23

-0.43%↓

Home・Listă Acțiuni・Royalty Pharma PLC (Class A)

Royalty Pharma PLC (Class A)

Deschisă

27.1

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

26.97

Maxim

27.25

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+63.3 upside

Dividende
By Dow Jones
Următoarele câștiguri	6 nov. 2024
Data viitoare de dividende	10 dec. 2024
Următoarea dată ex-dividende	15 nov. 2024

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

27.19 / 27.322 Suport & Rezistență

Royalty Pharma PLC (Class A) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

31 oct. 2024, 23:57 UTC

Acțiuni populare

Stocks to Watch: Intel, Amazon.com, Abbott Laboratories, MasTec

31 oct. 2024, 23:43 UTC

Câștiguri

Bud Light Owner's U.S. Sales Bounce Back After Boycott -- 4th Update

31 oct. 2024, 23:14 UTC

Principalele dinamici ale pieței

Abbott Laboratories Shares Rise After Baby-Formula Verdict

31 oct. 2024, 23:04 UTC

Top știri

Australian Manufacturing Activity Edges Up From Recessionary Lows

31 oct. 2024, 22:44 UTC

Câștiguri

Macquarie Lifts Dividend, Extends Buyback After 1st Half Profit Rises -- Update

31 oct. 2024, 22:14 UTC

Câștiguri

Macquarie Lifts Dividend, Extends Buyback After 1st Half Profit Rises

31 oct. 2024, 21:51 UTC

Top știri

Australian House Prices Rise 0.3% in October

31 oct. 2024, 21:50 UTC

Principalele dinamici ale pieței

Intel Shares Rally on 3Q Revenue, Upbeat Outlook

31 oct. 2024, 23:46 UTC

Top știri

Boeing Makes Another Offer to End Machinists Strike -- WSJ

31 oct. 2024, 23:23 UTC

Top știri

JPMorgan to Pay $151 Million for Alleged Misleading Disclosures, Other Charges -- Update

31 oct. 2024, 22:51 UTC

Top știri

Câștiguri

Intel Posts More Than $16 Billion Loss but Says Sales Outlook Is Improving -- 2nd Update

31 oct. 2024, 22:48 UTC

Top știri

Câștiguri

Amazon Shares Rise on Robust Demand, Surge in AI Infrastructure Spending -- WSJ

31 oct. 2024, 22:40 UTC

Market Talk

Achiziții, Fuziuni, Preluări

Strike Should Consider Selling Assets to Hancock -- Market Talk

31 oct. 2024, 22:29 UTC

Câștiguri

Macquarie Lifts Dividend, Extends Buyback After 1H Profit Rises -- Update

31 oct. 2024, 21:59 UTC

Câștiguri

Macquarie Lifts Dividend, Extends Buyback After 1H Profit Rises

31 oct. 2024, 21:57 UTC

Market Talk

Câștiguri

Intel Making Progress on $10B Cost Savings Push -- Market Talk

31 oct. 2024, 21:55 UTC

Top știri

Câștiguri

Intel Posts More Than $16 Billion Loss but Says Sales Outlook Is Improving -- Update

31 oct. 2024, 21:41 UTC

Top știri

Câștiguri

Chevron Could Rebound After a Middling Year -- Barrons.com

31 oct. 2024, 21:39 UTC

Câștiguri

Macquarie: Markets-Facing Activities A$1.4 Bln in Profit Contribution in 1H, Down 10% on Year

31 oct. 2024, 21:39 UTC

Câștiguri

Macquarie: Annuity-Style Activities A$1.6 Bln in Profit Contribution, Up 25% on Year

31 oct. 2024, 21:38 UTC

Câștiguri

Apple Beats September-Quarter Targets On iPhone, Services -- IBD

31 oct. 2024, 21:36 UTC

Câștiguri

Macquarie: Continues to Maintain Cautious Stance With Conservative Approach to Capital, Funding and Liquidity

31 oct. 2024, 21:35 UTC

Câștiguri

Macquarie: Has Acquired About A$1 Bln in Shares Through Buyback Program as of End-Oct

31 oct. 2024, 21:35 UTC

Câștiguri

Macquarie: Up to A$2 Bln Share Buyback Announced Last Year is Extended for 12 Months

31 oct. 2024, 21:33 UTC

Câștiguri

Macquarie: 1H Performance Also Driven by Further Progress in Digitalization in Banking and Financial Services

31 oct. 2024, 21:33 UTC

Câștiguri

Macquarie: Improved Performance in 1H Underpinned by Improved Realizations in Macquarie Asset Management

31 oct. 2024, 21:31 UTC

Câștiguri

Macquarie: Bank CET1 Level 2 Ratio 12.8%

31 oct. 2024, 21:31 UTC

Câștiguri

Macquarie: Financial Position Comfortably Exceeds Regulatory Minimum Requirements

31 oct. 2024, 21:30 UTC

Câștiguri

Macquarie: Assets Under Management A$917 Bln at End-Sept, Up 3% on Year

31 oct. 2024, 21:29 UTC

Câștiguri

Macquarie: International Income 65% of Total Income in 1H

Comparație

Modificare preț

Royalty Pharma PLC (Class A) Așteptări

Obiectiv de preț

By TipRanks

63.3% sus

Prognoză pe 12 luni

Medie 44.4 USD 63.3%

Maxim 51 USD

Minim 38 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruRoyalty Pharma PLC (Class A) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

5 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 5 analiști care au acordat evaluări ale acțiunilor Royalty Pharma PLC (Class A) - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

27.19 / 27.322Suport & Rezistență

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Date financiare

Alte acțiuni din sector

LLY

Eli Lilly and Co.

817.59

↓-1.55%

UNH

UnitedHealth Group Inc

566.44

↑ +0.03%

NVO

Novo Nordisk A-S

111.95

↑ +0.05%

JNJ

Johnson and Johnson

159.98

↑ +0.01%

ABBV

AbbVie Inc

203.23

↓-0.43%

Royalty Pharma PLC (Class A)

Rezumat

Modificarea prețului

Recomandări

Dividende

Scor tehnic

Royalty Pharma PLC (Class A) Grafic

Știri relevante

Comparație

Royalty Pharma PLC (Class A) Așteptări

Obiectiv de preț

Consens privind evaluarea

Scor tehnic

Date financiare

Alte acțiuni din sector

Informații cruciale despre conturile Facebook